$IPGP

SCHERBAKOV EUGENE A sold $155K of IPGP

SCHERBAKOV EUGENE A sold 1,524 shares of IPG PHOTONICS CORP (IPGP) at an average of $101.55 ($100.43–$106.66, $0.15M total) across 5 trades on 2026-06-29 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · SCHERBAKOV EUGENE A
Published Jul 1, 2026, 8:32 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 1, 2026, 8:51 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$IPGP
Neutral
medium confidence
Mentioned
$IPGP
Relevance
3/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$IPGPNeutralLow
01

Why it matters

A director/10% owner sold shares in multiple trades at $100.43–$106.66 (weighted avg $101.5466) totaling ~$154.8k, executed under a pre-arranged Rule 10b5-1 plan.

02

Market read

Traders may monitor for follow-on insider activity, but this specific disclosure is primarily a routine compliance event.

03

What to watch

The article provides no context on total insider holdings changes beyond the post-transaction figure, nor any concurrent company-specific catalyst; interpretive value is therefore limited.

Relevance 3/10Novelty 3/10Timing: Filed 2026-07-01 after 2026-06-29 insider sale execution

Background

The article is an SEC Form 4 insider transaction disclosure for IPG Photonics (IPGP).

Company-level read

Ticker impact

$IPGPNeutralMedium confidence
Context

IPG Photonics Form 4 shows director/10% owner sold 1,524 shares in open-market trades on 2026-06-29 under a 10b5-1 plan.

Expected impact

Low near-term impact; any effect is likely limited to short-lived sentiment around the filing date.

Evidence & confidence

The filing is a Form 4 insider transaction with an explicitly pre-arranged 10b5-1 plan, which typically reduces interpretive signal versus discretionary selling.

Market effects

Minimal—single-company insider sale without accompanying operational/regulatory news.

None indicated.

None indicated.

Counterpoint

Even with a 10b5-1 plan, repeated insider selling can still be read as confidence erosion by some traders, creating short-term sentiment pressure.

Key entities

  • IPG PHOTONICS CORP

    Subject of the Form 4 insider transaction; director/10% owner sold shares under a 10b5-1 plan.

  • SCHERBAKOV EUGENE A

    Director and 10% owner who executed the open-market sale(s).

Related articles

$IPGPMedAI 8/10

Why IPG Photonics Rallied Today

IPG Photonics (IPGP) shares rose 7.9% after the company reported mixed Q2 results and issued stronger-than-expected guidance. Revenue rose 11.1% to $278.6M, missing estimates, while adjusted EPS nearly doubled to $0.58. For Q3, IPG guided $280M revenue and $0.45 adjusted EPS at the midpoint.

$IPGPMed

IPG Photonics Q2 Earnings Call Highlights

IPG Photonics (IPGP) reported Q2 GAAP gross margin of 40.4% and adjusted gross margin of 40.7%, with GAAP diluted EPS of $0.12 and adjusted diluted EPS of $0.58. Management cited battery-manufacturing wins, additive manufacturing growth, and semiconductor momentum, plus CROSSBOW shipments for Lockheed Martin. IPG agreed to acquire Lumibird Medical, expected to close Q4 2026. Q3 revenue guidance is $265M to $295M.